In The News Posted July 11, 2019 Share Posted July 11, 2019 MONTGOMERY, Ala., July 11, 2019 /PRNewswire/ -- H2-Pharma, LLC, a privately held pharmaceutical company, announced today that it has entered into an agreement with CHEPLAPHARM Arzneimittel GmbH to be the exclusive U.S. distributor of ETOPOPHOS® (etoposide phosphate) for injection. This... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.